Cemiplimab (anti-PD-1)
Product Specifications
CAS Number
1801342-60-8
Synonyms
REGN-2810, cemiplimab-rwlc
SKU
C00022-1mg
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Cemiplimab (anti-PD-1) is an intravenous human monoclonal antibody directed against programmed cell death-1 receptor (PD-1) and blocks its interaction with programmed death ligands 1 (PD-L1) and 2 (PD-L2) . Cemiplimab blocks T-cell inactivation and enhances the immune system's anti-tumor response.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP762649 50 µg
Nogo B receptor (NUS1) (NM_138459) Human Recombinant Protein
Sign In for Pricing
View Details 
BNCB2581-100 1x 100 µL
HER-4 / ERBB4 (ERBB4/2581), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-A481525-250MG 250 mg
D-Alanine Benzyl Ester Benzenesulfonic Acid Salt
Sign In for Pricing
View Details